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To assess national expenditure associated with preterm-infant brain MRI and potential
impact of reduction per Choosing Wisely campaign 2015 recommendation to “avoid routine
screening term-equivalent or discharge brain MRIs in preterm-infants”. Cross-sectional U.S.
trend data from the Agency for Healthcare Research and Quality (AHRQ), Healthcare Cost
and Utilization Project (HCUP) Kids’ Inpatient Database (KID) database (2006, 2009, 2012,
2016) was used to estimate overall national expenditure associated with brain MRI among
infants with gestational age (GA)�36 weeks, and also when classified as ‘not indicated’ (NI-
MRI) i.e., equivalent to routine use without clinical indications and regarded as low-value
service (LVS). Associated cost was determined by querying CMS-database for physician-
fee-schedules to find the highest global procedure-cost per cycle, then adjusting for inflation.
Sensitivity-analyses were conducted to account for additional clinical charges associated
with NI-MRI. 3,768 (0.26%) of 1,472,236 preterm-infants had brain MRI across all cycles
(inflation-adjusted total $3,690,088). Overall proportion of brain MRIs increased across
2006–2012 from 0.25%-0.33% but decreased in 2016 to 0.16% (P<0.001). Inflation-
adjusted overall expenditure by cycle was: 2006, $1,299,130 (95% CI: $987,505,
$1,610,755); 2009, $1,194,208 (95% CI: $873,487, $1,516,154); 2012, $931,836 (95% CI:
$666,114, $1,197,156); and 2016, $264,648 (95% CI: $172,061, $357,280). Prevalence for
NI-MRI in 2006, 2009, 2012 and 2016 was 86% (n = 809), 88% (n = 940), 89% (n = 1028)
and 50% (n = 299), respectively; and 70% were in infants 35–36 weeks GA. NI-MRI preva-
lence was not different over time by payer-type (Medicaid, private), sex or race/ethnicity
(white, black, Hispanic); larger hospital size was significantly associated across 2006–2012
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but this declined for all sizes in 2016, with most decline in larger hospitals (P for interaction
<0.05). NI-MRI expenditure sensitivity-analysis with addition of cycle median total-admis-
sion-charge to inflation-adjusted CMS-fee was $1,190,919/$518,343, for 2012/2016 cycles
respectively. National MRI prevalence in preterm infants (both overall and LVS) and associ-
ated expenditure decreased substantially post recommendation; however, annual savings
are modest and unlikely to be >$1.2 million.
Introduction
In 2011 Berwick and Hackbarth estimated that overuse of medical services accounted for
roughly $200 billion in wasteful spending in the United States [1]. This led to the American
Board of Internal Medicine (ABIM) Foundation, Consumer Reports, and nine medical spe-
cialty societies launching the Choosing Wisely campaign in 2012, that was motivated by the
idea that health care professionals and specialty societies should take the lead in defining when
to avoid treatments and tests that are unnecessary or harmful—that is, low-value care [2, 3].
In an effort to reduce wasteful spending in perinatal care, the American Academy of Pediat-
rics (AAP) Section on Perinatal Pediatrics created a Top Five list of low value services (LVS) in
newborn medicine [4] as part of the Choosing Wisely campaign [5]. This LVS list targets tests
and treatments determined to be unjustified based on efficacy, safety, or cost, and decreased
use would therefore suggest a meaningful reduction in wasteful spending [4].
The Top Five list includes a recommendation to “avoid routine screening term-equivalent
or discharge brain MRIs in preterm infants” on the basis that there is “insufficient evidence
that the routine use of term-equivalent or discharge screening brain MRIs in preterm infants
improves long-term outcome” [4, 6, 7]; as such, routine MRI in this scenario can be regarded
as synonymous with LVS and not being clinically indicated. It is also likely that brain MRIs in
preterm infants further increase wasteful spending due to costs associated with additional clin-
ical investigation related to incidental findings [8, 9]. Ho et al. state that “roughly $60 million
or more (is) expended annually for brain MRIs in the ~ 60,000 very low birth weight infants
born each year in the US” [6].
The actual national prevalence and expenditure for brain MRI, however, whether overall,
or not indicated (i.e., equivalent to routine use without clinical indications and regarded as
LVS) in this clinical context is unclear. We chose to further study because this recommenda-
tion is associated with the most expensive LVS procedure identified on the Top Five list and
could potentially substantiate tens of millions of dollars reduction in wasteful spending [4, 6,
7]. Our objectives were: (1) to assess national prevalence of preterm infant brain MRI and
associated expenditure and impact of reduction per Choosing Wisely campaign recommenda-
tion; and (2) to examine factors that may be associated with LVS MRI prevalence.
Materials and methods
Our study utilized data from the most recent Agency for Healthcare Research and Quality
(AHRQ), Healthcare Cost and Utilization Project (HCUP) Kids’ Inpatient Database (KID). The
HCUP-KID database is a nationally representative sample of pediatric inpatient discharges; it
captures newborn/perinatal care and has been produced almost every three years since 1997.
Per AHRQ guidance this study utilized KID database statistical discharge weights to obtain
national estimates [10]. Our study used data available from 2006, 2009, 2012 and 2016 cycles,
which when weighted, estimates roughly 7 million hospitalizations per year [11].
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Brain MRIs among preterm infants were identified using available International Classifica-
tion of Diseases, Ninth and Tenth Revision (ICD-9 and ICD-10) diagnosis and procedure codes
[12]. Inclusion/exclusion criteria: ICD-9/10 diagnosis codes were used to choose preterm
infants with gestational age (GA)� 36 weeks (ICD-9: 76.521, 76.522, 76.523, 76.524, 76.525,
76.526, 76.527, 76.528; ICD-10: P07.22, P07.33, P07.35, P07.36, P07.37, P07.38, P07.39), among
which we then restricted our analysis to those who received a brain MRI using ICD-9 proce-
dure code 88.91 (2006–2012) and ICD-10 procedure code B030Y0Z (2016). Our dataset con-
sisted of 1,472,236 preterm infants from 2006, 2009, 2012, and 2016, and the extent of missing
data was < 5% for all variables, except for race which was 10.2%.
We first examined overall national prevalence of preterm infant brain MRI and associated
expenditure. Next we evaluated LVS MRI prevalence and the impact of reduction per recom-
mendation; for this analysis preterm infants who received brain MRIs were clinically classified
as “indicated” or “not indicated” (NI-MRI) using an assessment of procedure appropriateness
per diagnosis as follows. Not indicated imaging was assigned to routine screening term-equiv-
alent (TE) MRI performed on preterm infants who are at risk for adverse neurodevelopmental
outcome, without definitive clinical and/or cranial ultrasound findings that predispose to
underlying brain abnormality, whereas indicated imaging was assigned to MRI performed in
response to clinical scenarios and/or cranial ultrasound findings that raised concern for neuro-
logic abnormality [13]. A senior neonatologist (JYK) and senior pediatric neurologist (DGR)
independently reviewed all principal clinical diagnoses (i.e., KID data elements: DXn and
I10_DXn first listed diagnoses are the principal diagnoses defined as conditions established
after study to be chiefly responsible for occasioning the admission of the patient to the hospital
for care) with accompanying ICD-9/10 diagnosis codes in the selected preterm dataset for
appropriateness of MRI procedure indication. A preterm infant who received a brain MRI was
then classified as “indicated” vs. “non-indicated” by both physicians independently (i.e., physi-
cians performed classification in a blinded manner). Code discrepancies were subsequently
reconciled via discussion and consensus by the physicians and the final list of indicated/non-
indicated diagnoses is provided (see S1 Table). A kappa-statistic (measure of inter-rater agree-
ment) was calculated for ICD-9 and ICD-10 diagnoses classified as NI-MRI. This was found to
be 0.935 for ICD-9 and 0.9078 for ICD-10 (both P<0.001). These values indicated substantial
agreement between raters prior to code discrepancy reconciliation.
In consultation with clinical neonatologists and neurologists, we performed a contextually
informed systematic review of the KID data elements dictionary and included in our analysis
all covariates related to preterm infant brain MRI use and available across the database cycles
[14]: sex; payer type (Medicaid/private); race/ethnicity (black/white/Hispanic); hospital size
[(large/medium/small); per KID documentation—beginning in 2000, the hospital’s bed size
categories are defined using region of the U.S., the urban-rural designation of the hospital, in
addition to the teaching status [15]]; hospital type by teaching status (urban non-teaching/
urban teaching); hospital geographic region (Northeast/Midwest/South/West); total charges
($1000s); length of stay (days); and cycle year [15].
Overall expenditure was assessed using: (1) total admission charges from KID [the ‘total
charges’ covariate used is the cleaned KID data element and generally does not include profes-
sional fees and non-covered charges which are removed from the charge during HCUP pro-
cessing]; and (2) claims charges based on inflation-corrected fees for brain MRI, determined
by querying CMS online database for physician fee schedules to find the highest global proce-
dure cost per cycle for brain MRI [16] [the ‘highest CMS global procedure cost’ (i.e., both the
technical and professional components of the procedure) for the non-facility limiting charge
are selected as this is the maximum amount a beneficiary can be charged for the service, and
generally Medicare provides higher payments to physicians and other health care professionals
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for procedures performed in their offices because they are responsible for providing clinical
staff, supplies, and equipment] for relevant years [17]. First, baseline CMS fee cost estimates
are developed for each cycle, specifically: 2007 (as 2006 data not available), $1120; 2009, $932;
2012, $720; 2016, $415. Next, these estimates are corrected for inflation using an inflation cal-
culator [18] standardizing to 2020 cost, specifically: 2007, $1385; 2009, $1114; 2012, $804;
2016, $443. Sensitivity analyses were conducted to account for additional charges associated
with NI-MRI (per need for additional clinical investigation/ workup) using a combination of
these measures (i.e., by adding 10%, 25% and 50% of the total admission charge per cycle,
from the KID data to the inflation-corrected CMS fees, and then comparing cost estimates).
We assessed utilization trends across cycles by measuring prevalence of all preterm infant
brain MRI and, by indicated vs NI-MRI status, and then estimating associated expenditure.
We examined covariate associations by NI-MRI status. Multivariable generalized linear
regression models were used to estimate associations with outcomes of NI-MRI (vs. indicated)
and total charges (continuous value), overall and across cycles (predictive margins) and
reported as risk differences (RDs) with 95% confidence intervals (CIs). Interaction terms
between time (cycle/year) and covariates were included in fully specified multivariable models
and final models for trend in mean NI-MRI or total charges across cycles were adjusted for
sex, race, hospital size, hospital type, hospital region, and payer type. All analyses were con-
ducted using Stata statistical software, version 16 (Stata Corp., College Station, TX), and
account for complex survey design, and a common primary sampling unit survey weight vari-
able was created across KID database cycles for this analysis. All tests are two-sided with a
threshold for significance of 0.05.
Our study used deidentified admission claims data from a public registry and, after review
by University of Wisconsin-Milwaukee Institutional Review Board, was deemed to not involve
research with human subjects.
Results
Our dataset was representative of 1,472,236 preterm infants from 2006, 2009, 2012, and 2016
of which 0.26% (n = 3,768; 95% CI: 0.248, 0.264) received brain MRIs. Table 1 shows the distri-
bution of study baseline characteristics by LVS status (i.e., non-indicated vs. indicated status).
The prevalence of preterm infants who received brain MRIs increased marginally from 2006 to
2012 [2006: n = 938 (0.25%: 95% CI: 0.235, 0.268); 2009: n = 1,072 (0.29%: 95% CI: 0.270,
0.304); 2012: n = 1159 (0.33%: 95% CI: 0.313, 0.352)], but significantly decreased in 2016 to
0.16%: (n = 597; 95% CI: 0.144, 0.169). Across all years, 82% were NI-MRI (n = 3076) and 18%
were indicated (n = 692). The proportion of NI-MRI remained relatively constant across
2006–2012 [86% in 2006 (n = 809), 87% in 2009 (n = 940) and 89% 2012 (n = 1028)] but
declined significantly to 50% in 2016 (n = 299; P for trend <0.001).
There were no differences in distribution of NI-MRI among preterm infants based on sex,
payer type, race/ethnicity, and hospital type. However, significant differences were observed
based on hospital size and region, such that NI-MRI were more likely to be performed in large
hospitals and in the Northeast and West (all P<0.001).
Fig 1 shows the absolute prevalence of infants across GA and the study sample was right
skewed with most observations in the 35–36 weeks GA. In addition, 70% of NI-MRI occurred
in infants 35–36 weeks GA (S1 Fig). Results of multivariable modeling of risk factors associated
with non-indicated brain MRI status are provided in Table 2 below.
Fig 2 shows trends in LVS NI-MRI across cycles stratified by specific hospital/ insurance
factors. Hospital size, region and type demonstrated interaction with cycle (P for interaction
<0.05), while payer status did not. Hospitals in the Northeast had the highest NI-MRI rates
PLOS ONE An assessment of prevalence and expenditure associated with discharge brain MRI in preterm infants
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from 2006–2012 but decreased to be among the lowest in 2016 (Panel A). Urban non-teaching
vs. teaching hospitals were seen to have higher NI-MRI rates across 2006–2012, but both sub-
stantially decreased in 2016, with a larger decline in urban non-teaching (Panel B). Larger and
medium hospital size compared with small size was significantly associated with NI-MRI
across 2006–2012, but declined for all sizes in 2016, with the largest decline observed in larger
hospitals (Panel C). In addition, when GA was dichotomized as< 35 vs. 35–36 weeks, the
prevalence of MRI overall and NI-MRI (P for trend <0.05) were observed to decrease in the
2016 cycle among both subgroups compared with prior cycles (S2 Table).
Fig 3 shows trends in cost associated with preterm brain MRI across cycles. Total estimated
CMS fee-schedule-based cost for preterm brain MRI was $3,690,088 (inflation adjusted) for all
cycles, but this cost declined with each successive KID Cycle. Inflation adjusted overall expen-
diture by cycle was: 2006, $1,299,130 (95% CI: $987,505, $1,610,755); 2009, $1,194,208 (95%
CI: $873,487, $1,516,154); 2012, $931,836 (95% CI: $666,114, $1,197,156); and 2016, $264,648
(95% CI: $172,061, $357,280) (Panel A). Crude total charges for NI-MRI vs. indicated based
on KID data was significantly higher overall ($469,000 vs. $327,000; P<0.001), and trends for
Table 1. Distribution of population characteristics by MRI indication status.
Total (N = 3,768) Indicated Infant (n = 692) Non-Indicated Infant (n = 3,076) p-value
N N (W%a) N (W%a)
Sex 0.86
Male 2,064 382 (55.2) 1,683 (54.8)
Female 1,701 310 (44.8) 1,055 (44.6)
Race/Ethnicity 0.53
White 1,269 247 (40.3) 1,022 (37.0)
Black 630 114 (18.6) 516 (18.7)
Hispanic 912 156 (25.4) 756 (27.4)
Payer Type 0.72
Medicaid 2,057 387 (56.0) 1,670 (54.3)
Private 1,401 246 (35.6) 1,155 (37.6)
Hospital Size <0.001
Small 263 95 (14.4) 169 (5.7)
Medium 673 157 (23.9) 516 (17.3)
Large 2,694 406 (61.7) 2,288 (77.0)
Hospital Type 0.30
Urban non-teaching 370 49 (9.6) 321 (14.0)
Urban teaching 2,446 468 (90.4) 1,978 (86.1)
Hospital Region 0.01
Northeast 989 129 (18.6) 861 (28.0)
Midwest 569 125 (18.1) 444 (14.4)
South 981 246 (35.6) 735 (23.9)
West 1,227 192 (27.7) 1,036 (33.7)
Year <0.001
2006 938 129 (18.7) 809 (26.3)
2009 1,072 133 (19.2) 940 (30.6)
2012 1,159 131 (18.9) 1,028 (33.4)
2016 597 299 (43.3) 299 (9.7)
Mean Total Charge ($1,000) (SE) 442.3 (30.6) 326.6 (39.9) 468.8 (33.7) <0.001
aWeighted percentages, weighted to total discharged population in AHA universe.
https://doi.org/10.1371/journal.pone.0247857.t001
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total charges across cycles demonstrate almost linear increase over time (Panel B). However,
when KID data total charge was adjusted for length of stay, NI-MRI total charges were lower
across cycles and this difference was not found to be statistically significant (Panel C). Sensitiv-
ity analyses with addition of 10%, 25% and 50% of the total admission charge from the KID
Fig 1. Distribution infants across gestational age and by MRI indication status. a values are weighted absolute
numbers of indicated and non-indicated infants.
https://doi.org/10.1371/journal.pone.0247857.g001
Table 2. Multivariable generalized linear regression of risk factors for non-indicated brain MRIs1.
Covariate Coefficient SE 95% CI
Female [Reference: Male] 0.008 0.017 (-0.025, 0.042)
Race [Reference: White]
Black 0.042 0.021 (0.000, 0.084)
Hispanic 0.022 0.024 (-0.025, 0.068)
Hospital Size [Reference: Small]
Medium 0.089 0.068 (-0.044, 0.223)
Large 0.148 0.056 (0.038, 0.259)
Hospital Type [Reference: Urban, nonteaching]
Urban, teaching -0.010 0.028 (-0.065, 0.044)
Primary Payer [Reference: Medicaid]
Private insurance 0.004 0.022 (-0.039, 0.046)
Year [Reference: 2006]
2009 0.045 0.029 (-0.011, 0.102)
2012 0.026 0.030 (-0.034, 0.085)
2016 -0.367 0.052 (-0.469, -0.265)
1Survey weights used, weighted to total discharged population in AHA universe; model F-test: p< 0.0001; model
goodness of fit: p = 0.081
2Analyses were re-run with product terms. Results are demonstrated in the marginal plots shown in Fig 2.
https://doi.org/10.1371/journal.pone.0247857.t002
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Fig 2. Trends in LVS non-indicated MRI across cycles. Panel A: Stratified by Hospital Region. Panel B: Stratified by
Hospital Type. Panel C: Stratified by Hospital Size. Panel D: Stratified by Insurance Payer Type.
https://doi.org/10.1371/journal.pone.0247857.g002
Fig 3. Trends in cost associated with preterm brain MRI across cycles. Panel A: Total Inflation Corrected CMS Fee
Schedule Based Cost with 95% CIs for Preterm Brain MRI by KID cycle. Panel B: Unadjusted Mean Total Charge
across cycles by Indication Status. Panel C: Length of Stay Adjusted Mean Total Charge across cycles by Indication
Status. Panel D: Sensitivity Analysis for Additional Cost Related to Preterm Brain MRI.
https://doi.org/10.1371/journal.pone.0247857.g003
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data to the inflation adjusted CMS fees show cost associated with NI-MRI in 2012 to be
$896,222, $978.238, and $1,190,919, respectively; but decreased in 2016 to $204,221, $270,036,
and $518,343, respectively (Panel D). Hence, sensitivity analysis suggests a potential range of
annual savings of between $518,343 to $1,190,919 for reduction of LVS/routine NI-MRI based
on 2012 and 2016 cycles as most recent data.
Discussion
National health spending in the U.S., accounting for approximately 18% of Gross Domestic
Product (GDP), has been increasing at an alarming rate [19]. Recent CDC data show that U.S.
preterm birth rate (i.e. births at less than 37 weeks GA) rose from 9.57% to 9.85% during
2014–2016 [20], and 2018 data show 10% and 8.3% of 3,791,712 total births are described as
preterm and low birth weight (i.e.,< 2500 grams), respectively [21]. Ho et al. suggest that
roughly $60 million or more is expended annually for brain MRIs in approximately 60,000
very low birth weight infants born each year in the U.S., and it is likely that incidental findings
on MRI further increase waste due to costs associated with need for additional clinical investi-
gation [4–6, 8, 9]. Overall, these data suggest high prevalence of LVS/routine NI-MRI practice
and substantial wasteful spending.
Recently, Tolia et al. demonstrated the pattern of neuroimaging among infants� 33 weeks
between 2008 to 2017 [22]. They showed that the number of infants investigated with any neu-
roimaging modality declined during the 10-year period, driven primarily by a reduction in
cranial ultrasound in infants born at 31–33 weeks gestational age; however, MRI use in
those� 33 weeks increased until 2015, and then decreased [22].
Similarly, our study findings indicate that following implementation of Choosing Wisely in
newborn medicine in 2015, national MRI prevalence in preterm infants (both overall and
LVS) and associated expenditure decreased substantially post recommendation. Importantly,
compared with 2006–2012 cycles, the 2016 cycle shows a substantial decrease in the number of
LVS NI-MRIs in preterm infants (>86% vs. 50%, respectively). This suggests that the recom-
mendations to not perform so many non-indicated MRI’s was likely clinically embraced.
Overall, we also show that the national prevalence of MRIs is low, affecting only 0.26% of all
preterm infants over the four cycles. In addition, both the prevalence (0.16%) and calculated
reimbursement for MRI’s overall also significantly decreased in 2016. Hence, the cost-savings
associated with this Top Five guideline is modest; if all LVS NI-MRIs between 2012–2016 were
eliminated, nationwide savings would be estimated maximally at less than $5 million (using
sensitivity analysis with addition of cycle median total admission charge value); it should be
noted that these estimates are substantially lower than those previously stated by Ho et al. [6].
We are confident that this estimate would account for additional costs associated with further
workup due to incidental findings as recent reports indicate prevalence of incidental findings
on routine brain MRI in preterm infants at approximately 10% [8, 9].
Further, while reduction of NI-MRI would reduce excess healthcare spending, the relative
reduction would have a minimal impact on wasteful spending in children younger than one-
year which totaled $50.4 billion in 2013 alone [23]; and according to the U.S. Bureau of Labor
Statistics, prices for medical care were 17.2% higher in 2019 compared with 2013, which would
predict expected expenditure in this group to be closer to $59.1 billion [24]. Interestingly, we
found that large hospitals, those in the northeast, and urban non-teaching hospitals had higher
use of NI-MRI up to 2012, but this decreased significantly in 2016 and may be credited to
Choosing Wisely.
Ho et al. state that “studies must show that term-equivalent brain MRIs are superior to
neurodevelopmental evaluations, or less expensive than more accessible technologies like
PLOS ONE An assessment of prevalence and expenditure associated with discharge brain MRI in preterm infants
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intracranial ultrasound, to warrant routine use” [6]; these considerations highlight the impor-
tance of related procedure efficacy and costs. However, considering the modest cost-savings
for this specific LVS, from a public health and value-based care perspective, we advocate that
for true waste reduction to occur there must also be some consideration of procedure preva-
lence and estimates projected for associated cost-savings from reduction. Recently, Kerr et al.
advocated that for the Choosing Wisely campaign to have a meaningful impact on wasteful
healthcare spending, the LVS identified in the Top Five lists must be prioritized and evaluated
[3]; and our study contributes to such evaluation. As in the case of the Top Five list created by
the AAP Section on Perinatal Pediatrics, many of the guidelines generated as part of the Choos-
ing Wisely campaign, were chosen by practicing physicians in their respective field, without
the inclusion of public health professionals or health-economists [4]. As such, many of the
LVS included within the Top Five lists are heuristic-based procedures and practices that may
be infrequently used by health providers across the country.
National health spending in the U.S. is projected to reach $6.2 trillion by 2028 [19, 25].
Recently, Shrank et al. estimated that the cost of waste in the U.S. health care system ranged
from $760 billion to $935 billion, accounting for approximately 25% of total health care spend-
ing, and the projected potential savings from interventions that reduce waste, excluding sav-
ings from administrative complexity, ranged from $191 billion to $286 billion, representing a
potential 25% reduction in the total cost of waste; this highlights the need for implementation
of effective measures to eliminate waste and represents an opportunity to reduce the continued
increases in US health care expenditures [25, 26]. Wasteful spending is multifaceted and may
arise from the failure to deliver care [27], failure to coordinate care [28], overuse of tests, over-
treatment [3], administrative structures [29], regulation, and/or overpricing [30]. As such, a
multipronged approach is needed to effectively address this growing problem.
We acknowledge that performance of evidence-based indicated clinical procedures is
important, and that non-indicated MRI’s are stressful to infants and staff, frequently necessi-
tating sedation and close monitoring, and consuming valuable nursing and physician time as
well as equipment costs. Our study is the first to evaluate the prevalence and cost-savings of
reducing LVS brain NI-MRI among preterm infants in neonatal medicine. Screening TE MRI
was previously recommended for extremely preterm infants who are at risk for adverse neuro-
developmental outcome, including cerebral palsy, cognitive and language deficits, and neuro-
sensory impairment, depending on the region, as well as extent of perinatal and/or neonatal
brain injury [13]. The Choosing Wisely initiative aimed to discourage the routine use of TE
MRI screening in preterm infants because there is no evidence that it improves outcome as it
cannot predict cognitive and language outcome, or increased risk of autism, and does little to
allay parental anxiety about future neurodevelopmental outcomes [31]. While it is true that
utilization of this screening modality will not, in itself, improve outcome, it nevertheless may
inform the direction and intensity of rehabilitative services by providing actionable informa-
tion, before deficits are appreciated through neurological and developmental assessment dur-
ing follow-up clinical visits months after discharge [32]. Regarding the human brain, there are
still many unanswered questions and the literature and value of TE MRI continues to evolve.
A survey of members of the Newborn Brain Society in 2020, which included 504 responses
from 385 centers, elicited considerable variation in clinical practice with regards to obtaining
TE MRI in extremely low gestational age infants, not only in the U.S., but also in other parts of
the world and especially among different disciplines (i.e., neonatologist, neurologist, radiolo-
gist) [32]. Neurologists and radiologists indicated that TE MRI added value to clinical care and
decreased parental anxiety, whereas neonatologists were equivocal [32]; as such, there is con-
siderable overlap among many of these sub-specialties in support of TE MRI, especially since
one of the main barriers to obtaining TE MRI, i.e. the need for sedation, is currently not a
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major factor. The survey indicated that in the U.S., the majority of hospitals do not use seda-
tion for brain MRI in infants. Over the last decade multiple studies have demonstrated that TE
MRI has a role in predicting neurodevelopmental outcome in premature infants because of its
improved ability to assess cerebral development and injury, with MRI outperforming other
neuroimaging modalities, as well as clinical and physical exam as a predictive biomarker in
these infants [33–35]. Our findings therefore raise concern that an overinflated stated benefit
behind this Choosing Wisely recommendation (i.e., the overstated potential for annual health-
care savings of $60 million vs. actual of $1.2 million) could have the unintended consequence
of suppressing an emerging science regarding TE MRI and care should be taken to find the
appropriate balance; this broadly agrees with the recent viewpoint of Paul Fischer MD that
“While future research is needed, an agnostic approach right now denying all “routine” brain
MRIs at term for children born too early seems premature” [7].
Our study has some notable limitations. First, our cost estimates were calculated using the
highest global procedure cost for each study year cycle which may have resulted in an overesti-
mation of cost savings associated with LVS brain MRIs among preterm infants. Second, while
our dataset allowed us to readily identify LVS brain MRIs among preterm infants, we were
unable to examine other Top Five guidelines in newborn medicine with the same level of cer-
tainty. Third, it should be noted that the unit of analysis was hospital discharge rather than
individual infants which is a potential source of bias, as an infant may have several admissions
for the same illness episode, although the likelihood of such an occurrence is considered infre-
quent. Fourth, another limitation might be that the ICD codes reported do not reflect the
actual reason for ordering MRI scans and this could be a source of potential information bias.
On the other hand, our study has several strengths. First, no prior analysis has been con-
ducted to evaluate the cost-savings associated with the Top Five list of LVS among neonates.
As such, our study offers valuable insight into the financial impact of the Top Five list and per
Kerr et al. recommendations [3], supports progressive evaluation of effects of other LVS priori-
ties in newborn medicine. Second, we used a national population-based database representa-
tive of pediatric discharges throughout a diverse range of NICUs in the U.S. Third, we account
for additional expenditure associated with further workup for incidental finding by using sen-
sitivity analyses.
Despite yearly increases in costs, reducing excessive healthcare spending continues to be a
challenge within the U.S. as the healthcare landscape transitions from volume-based to value-
based services. While elimination of all wasteful spending should be the goal of providers
within the healthcare industry, initiatives and campaigns, such as Choosing Wisely, are essen-
tial to identify practices and policies that contribute significantly to unwarranted spending.
Beyond procedure efficacy and cost considerations, however, it will be important to use avail-
able national databases that incorporate disease prevalence to evaluate the magnitude of
impact both prior to and after guideline implementation. While a $60 million benefit has been
advocated regarding the impact of this Choosing Wisely recommendation, available data both
before and after implementation suggest a much smaller effect. Collaboration across disci-
plines (e.g., medicine, public health, health economics) will be critical to ensure these guide-
lines and recommendations are effective in reducing waste within the healthcare system.
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